MOH reviewing overseas MediSave scheme ahead of RTS Link opening as cross-border patient flow set to rise

The Singapore Ministry of Health is set to review its overseas MediSave scheme as the Johor Bahru-Singapore Rapid Transit System Link is slated to open in January 2027, Health Minister Ong Ye Kung revealed in a recent parliamentary reply, as reported by CNA. The review follows concerns that the expected surge in cross-border patient movement due to the new link may necessitate adjustments to the scheme's framework.

The overseas MediSave scheme allows Singaporean patients to utilize their MediSave funds for elective treatments at participating overseas hospitals, provided those facilities have a pre-existing agreement with a MediSave-accredited institution in Singapore. Currently, only two Malaysian hospitals, Mahkota Medical Centre and Regency Specialist Hospital, participate in the scheme through their local partner, HMI Medical Centre.

Despite being in place for over 15 years, the scheme's utilization remains relatively low, averaging around 300 claims annually from 2023 to 2025, primarily for obstetrics and gynaecology treatments. However, demand appears to be on the rise, with Regency Specialist Hospital reporting a doubling of Singaporean patients using MediSave since the COVID-19 pandemic.

The recent link is anticipated to significantly reduce the practical barriers to seeking medical treatment across the Causeway, making the current framework, designed for a much smaller volume of cross-border patients, potentially outdated. The Ministry of Health is currently reviewing the scheme in light of these anticipated changes, though no specific details regarding potential modifications were provided.